Literature DB >> 28607180

p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity.

Ayala Tovy1, Adam Spiro2, Ryan McCarthy3, Zohar Shipony2, Yael Aylon1, Kendra Allton3, Elena Ainbinder4, Noa Furth1, Amos Tanay2, Michelle Barton3, Moshe Oren1.   

Abstract

DNA methylation is a key regulator of embryonic stem cell (ESC) biology, dynamically changing between naïve, primed, and differentiated states. The p53 tumor suppressor is a pivotal guardian of genomic stability, but its contributions to epigenetic regulation and stem cell biology are less explored. We report that, in naïve mouse ESCs (mESCs), p53 restricts the expression of the de novo DNA methyltransferases Dnmt3a and Dnmt3b while up-regulating Tet1 and Tet2, which promote DNA demethylation. The DNA methylation imbalance in p53-deficient (p53-/-) mESCs is the result of augmented overall DNA methylation as well as increased methylation landscape heterogeneity. In differentiating p53-/- mESCs, elevated methylation persists, albeit more mildly. Importantly, concomitant with DNA methylation heterogeneity, p53-/- mESCs display increased cellular heterogeneity both in the "naïve" state and upon induced differentiation. This impact of p53 loss on 5-methylcytosine (5mC) heterogeneity was also evident in human ESCs and mouse embryos in vivo. Hence, p53 helps maintain DNA methylation homeostasis and clonal homogeneity, a function that may contribute to its tumor suppressor activity.
© 2017 Tovy et al.; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Keywords:  DNA methylation; p53; stem cells

Mesh:

Substances:

Year:  2017        PMID: 28607180      PMCID: PMC5495125          DOI: 10.1101/gad.299198.117

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  60 in total

1.  Hedgehog signaling is required for the differentiation of ES cells into neurectoderm.

Authors:  Peter Maye; Sandy Becker; Henrike Siemen; Jeffrey Thorne; Noah Byrd; Joseph Carpentino; Laura Grabel
Journal:  Dev Biol       Date:  2004-01-01       Impact factor: 3.582

2.  Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells.

Authors:  Zohar Shipony; Zohar Mukamel; Netta Mendelson Cohen; Gilad Landan; Elad Chomsky; Shlomit Reich Zeliger; Yael Chagit Fried; Elena Ainbinder; Nir Friedman; Amos Tanay
Journal:  Nature       Date:  2014-07-13       Impact factor: 49.962

3.  P53-Mediated Repression of the Reprogramming in Cloned Bovine Embryos Through Direct Interaction with HDAC1 and Indirect Interaction with DNMT3A.

Authors:  P J Ma; H Zhang; R Li; Y S Wang; Y Zhang; S Hua
Journal:  Reprod Domest Anim       Date:  2015-03-06       Impact factor: 2.005

4.  Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency.

Authors:  Lars Palmqvist; Clive H Glover; Lien Hsu; Min Lu; Bolette Bossen; James M Piret; R Keith Humphries; Cheryl D Helgason
Journal:  Stem Cells       Date:  2005-05       Impact factor: 6.277

5.  Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.

Authors:  Michael C Gundry; Lorenzo Brunetti; Angelique Lin; Allison E Mayle; Ayumi Kitano; Dimitrios Wagner; Joanne I Hsu; Kevin A Hoegenauer; Cliona M Rooney; Margaret A Goodell; Daisuke Nakada
Journal:  Cell Rep       Date:  2016-10-25       Impact factor: 9.423

6.  Metabolic oxidation regulates embryonic stem cell differentiation.

Authors:  Oscar Yanes; Julie Clark; Diana M Wong; Gary J Patti; Antonio Sánchez-Ruiz; H Paul Benton; Sunia A Trauger; Caroline Desponts; Sheng Ding; Gary Siuzdak
Journal:  Nat Chem Biol       Date:  2010-05-02       Impact factor: 15.040

7.  Stem cells: The promises and perils of p53.

Authors:  Valery Krizhanovsky; Scott W Lowe
Journal:  Nature       Date:  2009-08-27       Impact factor: 49.962

8.  Deregulation of DNA methyltransferases and loss of parental methylation at the insulin-like growth factor II (Igf2)/H19 loci in p53 knockout mice prior to tumor development.

Authors:  In Young Park; Bo Hwa Sohn; Jung Ha Choo; Cheol O Joe; Je Kyung Seong; Young Ik Lee; Jae Hoon Chung
Journal:  J Cell Biochem       Date:  2005-02-15       Impact factor: 4.429

9.  The maintenance of epigenetic states by p53: the guardian of the epigenome.

Authors:  Arnold J Levine; Benjamin Greenbaum
Journal:  Oncotarget       Date:  2012-12

10.  The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.

Authors:  Yael Aylon; Anat Gershoni; Ron Rotkopf; Inbal E Biton; Ziv Porat; Anna P Koh; Xiaochen Sun; Youngmin Lee; Maria-Isabel Fiel; Yujin Hoshida; Scott L Friedman; Randy L Johnson; Moshe Oren
Journal:  Genes Dev       Date:  2016-03-24       Impact factor: 11.361

View more
  20 in total

1.  The R882H substitution in the human de novo DNA methyltransferase DNMT3A disrupts allosteric regulation by the tumor supressor p53.

Authors:  Jonathan E Sandoval; Norbert O Reich
Journal:  J Biol Chem       Date:  2019-10-22       Impact factor: 5.157

Review 2.  Cell Death and the p53 Enigma During Mammalian Embryonic Development.

Authors:  Sonam Raj; Sushil K Jaiswal; Melvin L DePamphilis
Journal:  Stem Cells       Date:  2022-03-31       Impact factor: 5.845

Review 3.  p53: master of life, death, and the epigenome.

Authors:  Oleg Laptenko; Carol Prives
Journal:  Genes Dev       Date:  2017-05-15       Impact factor: 11.361

Review 4.  Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM.

Authors:  Kurt Engeland
Journal:  Cell Death Differ       Date:  2017-11-10       Impact factor: 15.828

Review 5.  Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.

Authors:  Eileen M McGowan; Yiguang Lin; Diana Hatoum
Journal:  Cancers (Basel)       Date:  2018-05-31       Impact factor: 6.639

6.  CGGBP1-regulated cytosine methylation at CTCF-binding motifs resists stochasticity.

Authors:  Manthan Patel; Divyesh Patel; Subhamoy Datta; Umashankar Singh
Journal:  BMC Genet       Date:  2020-07-29       Impact factor: 2.797

Review 7.  p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations.

Authors:  Tsukasa Oikawa; Yutaro Otsuka; Hisataka Sabe
Journal:  Cancers (Basel)       Date:  2018-05-25       Impact factor: 6.639

Review 8.  Putting p53 in Context.

Authors:  Edward R Kastenhuber; Scott W Lowe
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582

9.  The interplay of UV and cutaneous papillomavirus infection in skin cancer development.

Authors:  Daniel Hasche; Sonja Stephan; Ilona Braspenning-Wesch; Julita Mikulec; Martina Niebler; Hermann-Josef Gröne; Christa Flechtenmacher; Baki Akgül; Frank Rösl; Sabrina E Vinzón
Journal:  PLoS Pathog       Date:  2017-11-30       Impact factor: 6.823

Review 10.  New insights from the widening homogeneity perspective to target intratumor heterogeneity.

Authors:  Mengying Tong; Ziqian Deng; Xiaolong Zhang; Bin He; Mengying Yang; Wei Cheng; Quentin Liu
Journal:  Cancer Commun (Lond)       Date:  2018-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.